Biofrontera (BFRI)

• Market cap: $11.7M
• 1 day: 0%
• 5 days: 6.8%
• 1 month: 2.8%
• 3 months: 8.91%
• 6 months: 57.14%
• Year to date: 0.92%
• 1 year: 10%
• 5 years: -98.75%
• 10 years: -98.75%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.

Employees: 93